Asana stock drops 7% today as software names slide after CPI — what to watch next
13 January 2026
1 min read

Asana stock drops 7% today as software names slide after CPI — what to watch next

New York, Jan 13, 2026, 15:35 EST — Regular session

  • Asana shares dropped roughly 7% in afternoon trading, lagging behind the wider market.
  • In December, U.S. consumer inflation remained steady at 2.7% year-on-year, while “core” inflation stood at 2.6%.
  • Attention turns to the Fed’s January 27-28 meeting, with Asana’s fiscal year closing just days later on January 31.

Shares of Asana, Inc. dropped 7.1%, closing in on a session low of $11.87 before settling at $12.04 on Tuesday afternoon.

The decline followed a pullback in U.S. indexes after fresh inflation figures, as investors digested early bank earnings reports. The Dow slipped about 0.8%, while the S&P 500 and Nasdaq each dropped roughly 0.3%. “Markets seem to underappreciate the potential hazards,” noted David Wagner, head of equity and portfolio manager at Aptus Capital Advisors. (Investopedia)

The Labor Department reported U.S. consumer prices climbed 0.3% in December, marking a 2.7% increase compared to last year. Core inflation, excluding food and energy, inched up 0.2% for the month and stood 2.6% higher than a year ago. (Bureau of Labor Statistics)

Asana’s drop echoed struggles across cloud software names: Atlassian slipped around 5.2%, Monday.com dipped about 3.9%, and ServiceNow fell roughly 3.3%.

Company news was scarce, but Asana rolled out a product update late Monday. The highlight: “Scheduled Triggers,” a new time-based automation for its Rules tool. It also includes an AI-powered option to draft project status updates on a regular schedule. (Asana Forum)

On Sunday, research firm Wall Street Zen upgraded Asana from “hold” to “buy,” MarketBeat reported.

Asana reported Q3 revenue of $201.0 million on Dec. 2, marking a 9% increase. Its dollar-based net retention rate came in at 96%, indicating a slight drop in spending from existing customers compared to the previous year. The company projected Q4 revenue between $204 million and $206 million, raising its full-year revenue guidance to $789 million–$791 million. CFO Sonalee Parekh described Q3 as “another strong quarter of execution.” (Business Wire)

But the situation is double-edged. Asana is working to firm up retention and secure larger new contracts amid competition from bigger software players; any dip in IT budgets or a spike in bond yields could quickly hit high-multiple stocks hard, even if the company itself doesn’t release any news.

Asana’s stock has fallen roughly 31% in the last year, making it vulnerable to shifts in investor interest for smaller growth software companies.

Investors are eyeing the Federal Reserve’s policy meeting on Jan. 27-28 and Asana’s fiscal year-end on Jan. 31. That’s when focus usually shifts to how management discusses demand, retention, and forecasts for the year ahead. (Federal Reserve)

Stock Market Today

  • Aktis Oncology valuation under scrutiny after price move and ongoing losses
    January 13, 2026, 3:54 PM EST. Aktis Oncology (AKTS) has drawn attention after a roughly 3% intraday move and a 20.83% year-to-date gain as investors reassess its clinical radiopharmaceutical pipeline against a tight financial profile. The company posted US$5.56 million in revenue but a US$60.649 million loss, underscoring funding needs and ongoing clinical/regulatory risk. With negative equity, AKTS reports a Price-to-Book (-8.6x) that defies conventional comparisons (peer average ~3.8x; biotech industry ~2.7x). The negative equity makes the P/B metric less meaningful, highlighting capital-structure risk rather than a clear discount or premium. Liabilities are described as higher-risk funding sources. Readers should weigh the fundraising outlook and potential catalysts against the clinical timeline when judging entry points.
EchoStar stock slips as Crown Castle terminates DISH deal, raising fresh $3.5 billion overhang
Previous Story

EchoStar stock slips as Crown Castle terminates DISH deal, raising fresh $3.5 billion overhang

Oklo stock slides in late trade as Meta nuclear deal meets insider selling and long timelines
Next Story

Oklo stock slides in late trade as Meta nuclear deal meets insider selling and long timelines

Go toTop